NeuroQuant Suite & OnQ Platform
Neurodegenerative Disease, Multiple Sclerosis, Brain Tumors, Prostate Cancer
CommercialActive
Key Facts
Indication
Neurodegenerative Disease, Multiple Sclerosis, Brain Tumors, Prostate Cancer
Phase
Commercial
Status
Active
Company
About Cortechs.ai
Cortechs.ai is a commercial-stage AI diagnostics company specializing in quantitative medical imaging software for neurology and oncology. Founded in 2017, it commercializes technology with roots dating back to 1996, establishing its NeuroQuant® product as a clinical standard for brain MRI volumetry. The company has achieved significant commercial traction with over 1,400 hospitals and imaging centers as customers across 44 countries. Its strategy focuses on expanding its software suite, securing reimbursement via new CPT codes, and leveraging partnerships with major imaging equipment manufacturers.
View full company profile